The central target is the average of nine current price targets attributable to named analysts and firms. The most recent figures include $18 (TD Cowen, lowered from $20 in October 2026), $21 (Bank of America Securities), $24.50 (Freedom Broker, initiated with a Buy), $19 (Barclays), $26 (J.P. Morgan, raised from $22), $35 (Oppenheimer), $23 (Evercore ISI), $17 (Deutsche Bank), and $43 (Goldman Sachs, from its March 2026 initiation, not since revised).
That produces a mean of roughly $25.17, rounded to a central target of $25. The approximate low-to-high range is $17 to $43, and the wideness of that range is itself the key message: analysts agree on the direction of travel but not on how quickly margins can expand. Bullish firms emphasize distribution gains and operating leverage, while cautious firms argue that the company's losses and rich valuation limit near-term upside.
Once Upon A Farm is a Berkeley, California-based public benefit corporation (PBC) selling organic refrigerated fruit-and-veggie pouches, baby and kids snacks, and frozen meals. It completed its IPO in early 2026. Shares recently traded near $17.20, toward the lower-middle of a 52-week range of $14.00 to $27.00.
Reaching $25 requires a gain of about 45% from current levels — a very large move for a 12-month research horizon. Notably, $25 sits just below the stock's $27 post-IPO high, so the target implies recovering nearly all the ground lost since the spring. The path would most likely run through sustained top-line growth, progress toward profitability, and renewed multiple expansion if investor sentiment toward small-cap consumer staples improves.
The company's growth has been exceptional: revenue rose from about $94 million in fiscal 2023 to roughly $241 million in 2025, with consensus estimates pointing to roughly $332 million in 2026. Management has guided 2026 net sales to $327 million–$335 million, growth of 30%–34%, alongside adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $2 million–$4 million.
Analysts highlight three structural drivers: the core pouch business, which exceeds 60% of sales and benefits from thousands of in-aisle refrigerated coolers at retailers such as Target and Whole Foods; baby snacks, introduced in 2024 and already above 25% of sales; and a margin inflection as gross margins above 40% combine with SG&A leverage to push EBITDA toward positive territory.
The most direct obstacle is profitability. Trailing-twelve-month results show a net loss of roughly $9.5 million on about $288 million of revenue, and the company carries no meaningful net debt but a relatively high price-to-sales ratio near 2.4 for an unprofitable food business. If growth decelerates or margin expansion stalls, the multiple could compress sharply.
Competition in organic baby and kids food is intensifying, and the company's dependence on a handful of large retail partners adds concentration risk. Several Hold-rated analysts have already trimmed targets this year, and Deutsche Bank's $17 target sits slightly below the current price — a reminder that not every firm sees upside.
The stock's 52-week low of $14.00 (May 2026) serves as the key support zone, while the $27.00 high (February 2026) marks the main resistance area the stock would need to retake on the way to $25. The $25 target also sits near a psychological round-number level. With shares near $17.20, OFRM trades below its post-IPO high and roughly in line with its 100-day average, indicating the stock remains in a broad recovery range rather than a confirmed uptrend.
Analyst price targets generally reflect a roughly 12-month horizon, though individual firms differ, and the unrevised Goldman Sachs figure predates much of 2026. The next key catalyst is the company's quarterly earnings report, expected in early November 2026. Investors should watch revenue growth against the $327 million–$335 million guide, gross margin and adjusted EBITDA progress, any analyst target revisions, and broader sentiment toward small-cap consumer staples.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. For a name like OFRM, where analyst views are unusually divided, these signals can help traders spot momentum shifts, monitor positions, and identify changing trends more efficiently than manual screening. Explore the AI Daily Buy/Sell Signals to see how the tool currently reads the stock's setup.
Can OFRM reach $25? The question hinges on execution. The $25 central target — the mean of nine current analyst targets ranging from $17 to $43 — implies a very large, roughly 45% advance that would require the company to sustain high revenue growth while finally converting scale into profits. Bulls see a clear path through distribution expansion and margin leverage; bears and Hold-rated firms see a still-unprofitable business trading at a demanding multiple. With no Sell ratings but several cautious targets at or below the current price, the outcome likely depends on whether upcoming earnings confirm the margin inflection. Nothing here is a guarantee, and investors should weigh the wide analyst dispersion carefully.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.